When activist investors target drugmakers, drug-development strategies shift. Patients lose when this happens.
www.marketwatch.com
#pressure #money #faster #kill #lifesaving #pill
Related Posts

OpenAI reportedly missed revenue targets. Shares of Oracle and these chip stocks are falling
OpenAI CEO Sam Altman speaks during the BlackRock Infrastructure Summit on March 11, 2026 in Washington, DC. Anna Moneymaker |…

Futu (FUTU) Holdings Jumps 7% on Bullish Rating, Price Target Upgrade
We recently published These 10 Stocks Surprisingly Lead Gains While Wall Street Naps. Futu Holdings Limited (NASDAQ:FUTU) is one of this week’s…

Moderna to onshore drug product manufacturing to Massachusetts
Moderna is to expand its US manufacturing capabilities with the onshoring of drug product manufacture to its existing Moderna Technology…

